MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Mechanistic study of PARP9-mediated mitochondrial transfer in regulating dopaminergic neuronal injury and neuroinflammation in Parkinson’s disease

L. Liao, Z. Zhang (Guangzhou, Guangdong Province, China)

Meeting: 2026 International Congress

Keywords: Dopaminergic neurons, Microglial activation, Mitochondrial dysfunction

Category: Parkinson's Disease: Pathophysiology / molecular mechanisms of disease

Objective: To investigate PARP9 expression and localization in PD models, evaluate its effects on dopaminergic neuronal injury and microglial activation, and determine whether PARP9 regulates neuron–microglia mitochondrial transfer through TNTs.

Background: Parkinson’s disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra. Neuroinflammation, particularly microglial activation, plays an important role in PD progression. In our previous MPTP-induced PD mouse model, dopaminergic neuronal apoptosis and microglial activation were markedly increased in the substantia nigra. PARP9 has been associated with apoptosis and neuroinflammation in brain injury, but its role in PD remains unclear. Recent studies suggest that neurons and microglia can exchange mitochondria through tunneling nanotubes (TNTs), which may contribute to PD pathology.

Method: An MPTP-induced PD mouse model and a neuron (SH-SY5Y)–microglia (HMC3) co-culture system were used. PARP9 expression and localization were assessed by immunohistochemistry, immunofluorescence, and Western blotting. AAV-mediated knockdown/overexpression and siRNA transfection were used to modulate PARP9 expression in vivo and in vitro. Neuronal apoptosis and inflammatory cytokines were evaluated by TUNEL, Western blotting, immunofluorescence, and ELISA. MitoTracker labeling, Phalloidin staining, and confocal microscopy were used to assess mitochondrial transfer, TNT formation, and mitochondrial function.

Results: MPTP-treated mice showed reduced TH-positive neurons and increased Iba1-positive microglial activation in the substantia nigra pars compacta. PARP9 expression was significantly upregulated in the midbrain substantia nigra and co-localized with TH-positive neurons and Iba1-positive microglia. PARP9 knockdown alleviated neuronal apoptosis and neuroinflammation, whereas PARP9 overexpression aggravated both processes.

Conclusion: PARP9 upregulation may disrupt TNT-mediated mitochondrial transfer between neurons and microglia, impair mitochondrial homeostasis, aggravate dopaminergic neuronal apoptosis, and promote microglial activation and inflammatory cytokine release, thereby accelerating PD progression.

To cite this abstract in AMA style:

L. Liao, Z. Zhang. Mechanistic study of PARP9-mediated mitochondrial transfer in regulating dopaminergic neuronal injury and neuroinflammation in Parkinson’s disease [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/mechanistic-study-of-parp9-mediated-mitochondrial-transfer-in-regulating-dopaminergic-neuronal-injury-and-neuroinflammation-in-parkinsons-disease/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/mechanistic-study-of-parp9-mediated-mitochondrial-transfer-in-regulating-dopaminergic-neuronal-injury-and-neuroinflammation-in-parkinsons-disease/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley